ESTA (Establishment Labs Holdings) EPS (Basic) : $-2.58 (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings EPS (Basic)?

Establishment Labs Holdings's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was $-0.59. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.58.

Establishment Labs Holdings's EPS (Diluted) for the three months ended in Sep. 2024 was $-0.59. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.58.

Establishment Labs Holdings's EPS without NRI for the three months ended in Sep. 2024 was $-0.59. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -2.58.

During the past 3 years, the average EPS without NRI Growth Rate was -22.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Establishment Labs Holdings's highest 3-Year average EPS without NRI Growth Rate was 2.00% per year. The lowest was -22.10% per year. And the median was -9.00% per year.

Establishment Labs Holdings EPS (Basic) Historical Data

The historical data trend for Establishment Labs Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings EPS (Basic) Chart

Establishment Labs Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-1.86

-1.63

-1.72

-3.08

-3.07

Establishment Labs Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-1.12	-0.79	-0.58	-0.62	-0.59

Establishment Labs Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Establishment Labs Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-78.502	-	0)	/	25.600
	=	-3.07

Establishment Labs Holdings's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.682	-	0)	/	28.248
	=	-0.59

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.58

Establishment Labs Holdings (NAS:ESTA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Establishment Labs Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Establishment Labs Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

3E0:Germany

Address

Coyol Free Zone, Building B15 and 25, Alajuela, CRI

Website

https://establishmentlabs.com

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Executives

Chacon Quiros Juan Jose	director, officer: Chief Executive Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Nicholas Sheridan Lewin	director, 10 percent owner	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy	officer: Chief Financial Officer	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon	director	811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach	other: GC & Chief Compliance Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Jw Asset Management, Llc	10 percent owner, other: See Footnote(1)	1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Bryan Slotkin	director	C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter	director	C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh	director	C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De	officer: Chief Technology Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta	officer: Chief Financial Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar	officer: Head of Global Operations	150 PEABODY PLACE, MEMPHIS TN 38103